Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850, an mGlu2 agonist/mGlu3 antagonist

Lydia Hanna, Laura Ceolin, Sarah Lucas, James Monn, Bryan Johnson, Graham Collingridge, Zuner Bortolotto, David Lodge
  • Neuropharmacology, March 2013, Elsevier
  • DOI: 10.1016/j.neuropharm.2012.02.023
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
Read Publication

http://dx.doi.org/10.1016/j.neuropharm.2012.02.023

The following have contributed to this page: Professor Graham L Collingridge